Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TCRX | BMY | AMGN | GILD | REGN |
| Company | Tscan Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 6.82 | 48.21 | 264.63 | 66.25 | 913.97 |
| High | 7.13 | 48.59 | 266.79 | 66.72 | 920.73 |
| Low | 6.82 | 48.12 | 260.68 | 66.16 | 891.61 |
| Last | 6.98 | 48.57 | 266.59 | 66.33 | 893.22 |
| Change | +0.06 | +0.27 | +3.84 | +0.17 | -0.77 |
| % Change | +0.87% | +0.56% | +1.46% | +0.26% | -0.09% |
| Volume | 67,904 | 2,628,910 | 822,988 | 2,598,411 | 164,895 |
| 20-Day Average Volume | 287,747 | 10,910,723 | 2,115,952 | 6,044,857 | 420,269 |
| Previous Close | 6.92 | 48.30 | 262.75 | 66.16 | 893.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 7.49 | 50.83 | 272.42 | 69.88 | 934.98 |
| 20-Day Raw Stochastic | 16.94% | 13.34% | 19.04% | 6.15% | 2.78% |
| 20-Day Relative Strength | 49.02% | 38.88% | 40.70% | 29.25% | 33.10% |
| Weighted Alpha | +113.34 | -29.70 | +6.05 | -24.91 | +11.74 |
| Today's Opinion | 64% Buy | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 64% Buy | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 100% Buy | 24% Sell | 8% Sell | 72% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.81% since 04/12/24 | +0.52% since 04/12/24 | -0.48% since 04/12/24 | -2.47% since 04/12/24 | -1.31% since 04/12/24 |
| Low | 6.58 on 04/17/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 7.92 on 04/15/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 921.12 on 04/15/24 |
| 1-Month | |||||
| %Chg | +0.29% since 03/19/24 | -6.31% since 03/19/24 | -2.11% since 03/19/24 | -9.56% since 03/19/24 | -7.35% since 03/19/24 |
| Low | 6.58 on 04/17/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 9.00 on 03/27/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | +29.68% since 01/19/24 | -3.15% since 01/19/24 | -13.59% since 01/19/24 | -23.94% since 01/19/24 | -4.34% since 01/19/24 |
| Low | 4.64 on 01/25/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 9.00 on 03/27/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +106.19% since 10/19/23 | -14.08% since 10/19/23 | -5.21% since 10/19/23 | -15.36% since 10/19/23 | +10.41% since 10/19/23 |
| Low | 2.86 on 10/23/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 9.00 on 03/27/24 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 331,343 | 97,892,464 | 140,812,720 | 82,374,304 | 98,126,128 |
| Shares Outstanding, K | 47,882 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
| Annual Sales | 21,050,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -89,220,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 7,210,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -19,610,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.90 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 03/06/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/08/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 9.96 | 23.98 |